Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial

Documenti analoghi

• Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
  di: Suzuki, Shuichi, et al.
  Pubblicazione: (2017)
• Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study
  di: Ishii, Hitoshi, et al.
  Pubblicazione: (2019)
• Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
  di: Onishi, Yukiko, et al.
  Pubblicazione: (2020)
• Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog(®) in Japanese patients with type 1 diabetes
  di: Shiramoto, Masanari, et al.
  Pubblicazione: (2020)
• The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
  di: Inagaki, Nobuya, et al.
  Pubblicazione: (2016)